Indie Asset Partners, LLC Amgen Inc Transaction History

Indie Asset Partners, LLC

$129 Million
Q3 2024

A detailed history of Indie Asset Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Indie Asset Partners, LLC holds 1,130 shares of AMGN stock, worth $332,818. This represents 0.28% of its overall portfolio holdings.

Number of Shares

1,130

Previous 1,128 0.18%

Holding current value

$332,818

Previous $352,000 3.41%

% of portfolio

0.28%

Previous 0.29%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $618 - $674	2 Added 0.18%	1,130 $364,000
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $21,282 - $25,864	81 Added 7.74%	1,128 $352,000
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $2,957 - $3,570	11 Added 1.06%	1,047 $297,000
Q4 2023 Jan 26, 2024	SELL	$255.7 - $288.46 $1,278 - $1,442	-5 Reduced 0.48%	1,036 $298,000
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $1,499 - $1,773	-7 Reduced 0.67%	1,041 $231,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $17,303 - $19,255	-75 Reduced 6.68%	1,048 $255,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $43,554 - $49,844	-219 Reduced 16.32%	1,123 $253,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $10,613 - $12,435	-50 Reduced 3.59%	1,342 $285,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $53,723 - $59,602	-230 Reduced 14.18%	1,392 $339,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $2,163 - $2,576	10 Added 0.62%	1,622 $373,000
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $28,682 - $35,197	-145 Reduced 8.25%	1,612 $384,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $18,224 - $24,170	-100 Reduced 5.39%	1,757 $356,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $351,362 - $451,622	1,857 New	1,857 $448,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indie Asset Partners, LLC with notifications on news.

Account

Indie Asset Partners, LLC Amgen Inc Transaction History